title: [Clinical value of "zero-hour biopsy"].
abstract: In spite of the improving results the long-term benefits of renal transplantation fell behind the expectable potential possibilities. The main cause of kidney graft loss is chronic allograft nephropathy following cardiovascular deaths. This is such a multiple etiologic clinical picture which may occur at any time. When adequate treatment is not available in time repeated development of chronic renal failure is unavoidable. The aim of my study is, how can we rise the number of transplanted kidney and the quality of them.
authors.affiliation: Pécsi Tudományegyetem KK Sebészeti Klinika 7643 Pécs Ifjúság útja 13. szakaly@iseb.pote.hu
authors.forename: Péter
authors.initials: P
authors.lastname: Szakály
mesh_terms: D000818:Animals; D001706:Biopsy / Q000379:methods; D001926:Brain Death; D002470:Cell Survival / Q000187:drug effects; D005060:Europe; D005923:Glomerulosclerosis, Focal Segmental / Q000209:etiology / Q000517:prevention & control; D006085:Graft Survival / Q000187:drug effects*; D006801:Humans; D006814:Hungary; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007668:Kidney / Q000187:drug effects / Q000473:pathology*; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D016030:Kidney Transplantation / Q000592:standards; D008297:Male; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000627:therapeutic use; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide / Q000627:therapeutic use* / Q000648:ultrastructure; D016730:Program Development; D051381:Rats; D017208:Rats, Wistar; D051436:Renal Insufficiency, Chronic / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology / Q000503:physiopathology / Q000517:prevention & control*; D015427:Reperfusion Injury / Q000209:etiology / Q000517:prevention & control*; D020858:Tissue and Organ Harvesting / Q000379:methods; D014184:Transplantation, Homologous
chemical_list: D007166:Immunosuppressive Agents; D018696:Neuroprotective Agents; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide